Low-dose heparin to low molecular weight heparin prophylaxis: in pursuit of excellence - a personal perspective.
Kakkar
V V
VV
Thrombosis Research Institute, Chelsea, London SW3 6LR, UK. director@tri-london.ac.uk
D006493:Heparin / Q000266:history* / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000266:history* / Q000627:therapeutic use; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D019990:Perioperative Care; D011292:Premedication; D013923:Thromboembolism / Q000175:diagnosis / Q000188:drug therapy / Q000266:history / Q000517:prevention & control; D020246:Venous Thrombosis / Q000175:diagnosis / Q000188:drug therapy / Q000266:history / Q000517:prevention & control
D006495:Heparin, Low-Molecular-Weight; D006493:Heparin